Article
Researchers from the Department of Dermatology, Massachusetts General Hospital, and Harvard Medical School in Boston administered twice-weekly 308-nm UV-B radiation to selected vitiligo lesions for a maximum of 60 treatments.
The Weekly Roundup: October 7-11
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Safe and Effective: Upadacitinib Shows Promise in PN Treatment
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Fourth Ustekinumab Biosimilar, Otulfi, Approved in US
Philip Mease, MD, Discusses Head-to-Head BE BOLD Clinical Trial